Tenofovir renal toxicity targets mitochondria of renal proximal tubules
Open Access
- 9 March 2009
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 89 (5) , 513-519
- https://doi.org/10.1038/labinvest.2009.14
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Cardiac-Targeted Transgenic Mutant Mitochondrial Enzymes: mtDNA Defects, Antiretroviral Toxicity and CardiomyopathyCardiovascular Toxicology, 2008
- Effect of tenofovir on renal glomerular and tubular functionAIDS, 2007
- Absence of a Universal Mechanism of Mitochondrial Toxicity by Nucleoside AnalogsAntimicrobial Agents and Chemotherapy, 2007
- Decreased mtDNA, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase γLaboratory Investigation, 2007
- Targeted Transgenic Overexpression of Mitochondrial Thymidine Kinase (TK2) Alters Mitochondrial DNA (mtDNA) and Mitochondrial Polypeptide Abundance: Transgenic TK2, mtDNA, and AntiretroviralsThe American Journal of Pathology, 2007
- In Vitro Cytotoxicity and Mitochondrial Toxicity of Tenofovir Alone and in Combination with Other Antiretrovirals in Human Renal Proximal Tubule CellsAntimicrobial Agents and Chemotherapy, 2006
- Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B VirusAntimicrobial Agents and Chemotherapy, 2006
- Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol γ hypothesisAIDS, 2006
- Tenofovir Disoproxil FumarateDrugs, 2005
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990